• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大鼠脑局灶性缺血后多聚(ADP - 核糖)化增强

Enhanced poly(ADP-ribosyl)ation after focal ischemia in rat brain.

作者信息

Tokime T, Nozaki K, Sugino T, Kikuchi H, Hashimoto N, Ueda K

机构信息

Department of Neurosurgery, Faculty of Medicine, Kyoto University, Japan.

出版信息

J Cereb Blood Flow Metab. 1998 Sep;18(9):991-7. doi: 10.1097/00004647-199809000-00008.

DOI:10.1097/00004647-199809000-00008
PMID:9740102
Abstract

Nitric oxide from neuronal cells plays detrimental roles in glutamate neurotoxicity and in focal brain ischemia. Nitric oxide directly damages DNA, and breaks in the DNA strands activate poly(ADP-ribose) polymerase (PARP), which brings poly(ADP-ribosyl)ation of the nuclear proteins. The excessive activation of PARP is thought to cause depletion of ATP and the energy failure resulting in cell death. To clarify the involvement of poly(ADP-ribosyl)ation in ischemic insult, we examined poly(ADP ribosyl)ation by immunohistochemical methods and the protective effect of 3-aminobenzamide, which is a PARP inhibitor, on focal brain ischemia using an intraluminal permanent middle cerebral artery occlusion model in rats. Poly(ADP ribosyl)ation was widely and markedly detected 2 hours after the ischemic insult in the cerebral cortex and striatum in which infarction developed 24 hours later. The enhanced immunoreactivity of poly(ADP-ribose) gradually decreased, and 16 hours later, no immunoreactivity was detected. Intraventricular administration of 3-aminobenzamide (1 to 30 mg/kg) 30 minutes before the ischemic insult decreased infarction volume in a dose-dependent manner along with the immunohistochemical reduction of poly(ADP-ribosyl)ation. Pretreatment with 7-nitroindazole (25 mg/kg, intraperitoneally), a selective neuronal nitric oxide synthetase inhibitor, partially reduced poly(ADP-ribosyl)ation. These data suggest the involvement of poly(ADP-ribosyl)ation in the development of cerebral infarction.

摘要

来自神经细胞的一氧化氮在谷氨酸神经毒性和局灶性脑缺血中起有害作用。一氧化氮直接损伤DNA,DNA链的断裂激活聚(ADP - 核糖)聚合酶(PARP),从而使核蛋白发生聚(ADP - 核糖基)化。PARP的过度激活被认为会导致ATP耗竭和能量衰竭,进而导致细胞死亡。为了阐明聚(ADP - 核糖基)化在缺血性损伤中的作用,我们采用免疫组织化学方法检测聚(ADP - 核糖基)化,并使用大鼠管腔内永久性大脑中动脉闭塞模型,研究PARP抑制剂3 - 氨基苯甲酰胺对局灶性脑缺血的保护作用。在缺血性损伤后2小时,在24小时后发生梗死的大脑皮层和纹状体中广泛且明显地检测到聚(ADP - 核糖基)化。聚(ADP - 核糖)增强的免疫反应性逐渐降低,16小时后未检测到免疫反应性。在缺血性损伤前30分钟脑室内注射3 - 氨基苯甲酰胺(1至30 mg/kg),梗死体积以剂量依赖方式减小,同时聚(ADP - 核糖基)化的免疫组织化学染色减弱。用选择性神经元一氧化氮合酶抑制剂7 - 硝基吲唑(25 mg/kg,腹腔注射)预处理可部分降低聚(ADP - 核糖基)化。这些数据表明聚(ADP - 核糖基)化参与了脑梗死的发生发展。

相似文献

1
Enhanced poly(ADP-ribosyl)ation after focal ischemia in rat brain.大鼠脑局灶性缺血后多聚(ADP - 核糖)化增强
J Cereb Blood Flow Metab. 1998 Sep;18(9):991-7. doi: 10.1097/00004647-199809000-00008.
2
Poly(ADP-ribosyl)ation and stroke.聚(ADP - 核糖)化与中风
Pharmacol Res. 2005 Jul;52(1):15-24. doi: 10.1016/j.phrs.2005.02.018.
3
Increased poly(ADP-ribosyl)ation in peripheral leukocytes and the reperfused myocardium tissue of rats with ischemia/reperfusion injury: prevention by 3-aminobenzamide treatment.缺血/再灌注损伤大鼠外周血白细胞和再灌注心肌组织中多聚(ADP-核糖)化的增加:3-氨基苯甲酰胺治疗的预防作用。
Shock. 2012 May;37(5):492-500. doi: 10.1097/SHK.0b013e31824989d7.
4
Repression of phosphoenolpyruvate carboxykinase gene activity by insulin is blocked by 3-aminobenzamide but not by PD128763, a selective inhibitor of poly(ADP-ribose) polymerase.胰岛素对磷酸烯醇式丙酮酸羧激酶基因活性的抑制作用被3-氨基苯甲酰胺阻断,但不被聚(ADP-核糖)聚合酶的选择性抑制剂PD128763阻断。
Eur J Biochem. 1998 Apr 1;253(1):91-100. doi: 10.1046/j.1432-1327.1998.2530091.x.
5
Distribution of Poly(ADP-ribosyl)ation and cell death after cerebral ischemia in the neonatal rat.新生大鼠脑缺血后聚(ADP-核糖基)化的分布与细胞死亡
Pediatr Res. 2003 May;53(5):776-82. doi: 10.1203/01.PDR.0000059751.00465.F6. Epub 2003 Mar 5.
6
A newly synthesized poly(ADP-ribose) polymerase inhibitor, DR2313 [2-methyl-3,5,7,8-tetrahydrothiopyrano[4,3-d]-pyrimidine-4-one]: pharmacological profiles, neuroprotective effects, and therapeutic time window in cerebral ischemia in rats.一种新合成的聚(ADP - 核糖)聚合酶抑制剂DR2313 [2 - 甲基 - 3,5,7,8 - 四氢硫代吡喃并[4,3 - d]嘧啶 - 4 - 酮]:大鼠脑缺血中的药理学特性、神经保护作用及治疗时间窗
J Pharmacol Exp Ther. 2005 Feb;312(2):472-81. doi: 10.1124/jpet.104.075465. Epub 2004 Oct 1.
7
Inhibition of neuronal nitric oxide synthase-mediated activation of poly(ADP-ribose) polymerase in traumatic brain injury: neuroprotection by 3-aminobenzamide.抑制创伤性脑损伤中神经元型一氧化氮合酶介导的聚(ADP-核糖)聚合酶激活:3-氨基苯甲酰胺的神经保护作用
Neuroscience. 2003;121(4):983-90. doi: 10.1016/s0306-4522(03)00482-2.
8
Blockade of PARP activity attenuates poly(ADP-ribosyl)ation but offers only partial neuroprotection against NMDA-induced cell death in the rat retina.抑制聚(ADP - 核糖)聚合酶(PARP)活性可减弱聚(ADP - 核糖)基化作用,但对大鼠视网膜中N - 甲基 - D - 天冬氨酸(NMDA)诱导的细胞死亡仅提供部分神经保护作用。
J Neurochem. 2006 Sep;98(6):1732-45. doi: 10.1111/j.1471-4159.2006.04065.x. Epub 2006 Aug 11.
9
Glucocorticoid-induced cell death and poly[adenosine diphosphate(ADP)-ribosyl]ation: increased toxicity of dexamethasone on mouse S49.1 lymphoma cells with the poly(ADP-ribosyl)ation inhibitor benzamide.糖皮质激素诱导的细胞死亡与多聚[腺苷二磷酸(ADP)-核糖基]化:多聚(ADP-核糖基)化抑制剂苯甲酰胺增强地塞米松对小鼠S49.1淋巴瘤细胞的毒性。
Endocrinology. 1986 Nov;119(5):2383-92. doi: 10.1210/endo-119-5-2383.
10
Long-term neuroprotective effect of inhibiting poly(ADP-ribose) polymerase in rats with middle cerebral artery occlusion using a behavioral assessment.使用行为学评估方法研究抑制聚(ADP - 核糖)聚合酶对大脑中动脉闭塞大鼠的长期神经保护作用。
Brain Res. 2001 Oct 12;915(2):210-7. doi: 10.1016/s0006-8993(01)02852-9.

引用本文的文献

1
Molecular Mechanisms of Parthanatos and Its Role in Diverse Diseases.细胞坏死性凋亡的分子机制及其在多种疾病中的作用。
Int J Mol Sci. 2022 Jun 30;23(13):7292. doi: 10.3390/ijms23137292.
2
Poly (ADP-ribose) polymerase: An Overview of Mechanistic Approaches and Therapeutic Opportunities in the Management of Stroke.聚(ADP-核糖)聚合酶:在脑卒中管理中机制方法和治疗机会的概述。
Neurochem Res. 2022 Jul;47(7):1830-1852. doi: 10.1007/s11064-022-03595-z. Epub 2022 Apr 18.
3
Emerging role of PARP-1 and PARthanatos in ischemic stroke.PARP-1 和 PARthanatos 在缺血性脑卒中中的作用日益凸显。
J Neurochem. 2022 Jan;160(1):74-87. doi: 10.1111/jnc.15464. Epub 2021 Jul 28.
4
Anti-Inflammatory and Neuroprotective Effects of Co-UltraPEALut in a Mouse Model of Vascular Dementia.联合超顺磁性氧化铁纳米粒子在血管性痴呆小鼠模型中的抗炎和神经保护作用
Front Neurol. 2017 Jun 6;8:233. doi: 10.3389/fneur.2017.00233. eCollection 2017.
5
Co-ultramicronized Palmitoylethanolamide/Luteolin in the Treatment of Cerebral Ischemia: from Rodent to Man.超微细化棕榈酰乙醇胺/木犀草素联合治疗脑缺血:从啮齿动物到人类
Transl Stroke Res. 2016 Feb;7(1):54-69. doi: 10.1007/s12975-015-0440-8. Epub 2015 Dec 26.
6
Role of C/EBP homologous protein in retinal ganglion cell death after ischemia/reperfusion injury.C/EBP 同源蛋白在缺血/再灌注损伤后视网膜神经节细胞死亡中的作用。
Invest Ophthalmol Vis Sci. 2014 Nov 20;56(1):221-31. doi: 10.1167/iovs.14-15447.
7
Parthanatos: mitochondrial-linked mechanisms and therapeutic opportunities.PARP-1介导的细胞坏死:线粒体相关机制与治疗机遇
Br J Pharmacol. 2014 Apr;171(8):2000-16. doi: 10.1111/bph.12416.
8
Stereotactic coordinates for intracerebroventricular infusion after permanent focal cerebral ischemia in Wistar rats.Wistar大鼠永久性局灶性脑缺血后脑室内注射的立体定向坐标。
Hippokratia. 2012 Jan;16(1):51-6.
9
NAD+ depletion or PAR polymer formation: which plays the role of executioner in ischaemic cell death?NAD+ 耗竭还是 PAR 聚合物形成:在缺血性细胞死亡中谁是执行者?
Acta Physiol (Oxf). 2011 Sep;203(1):225-34. doi: 10.1111/j.1748-1716.2010.02229.x. Epub 2011 Jan 19.
10
Oxidative stress and NAD+ in ischemic brain injury: current advances and future perspectives.氧化应激与缺血性脑损伤中的 NAD+:当前进展与未来展望。
Curr Med Chem. 2010;17(20):2152-8. doi: 10.2174/092986710791299911.